WARNING! THE NEW ‘MIRACLE’ CURE  FOR COVID-19 CAN CAUSE SEVERE EYE DAMAGE

Retinal toxicity associated with chronic exposure to hydroxychloroquine and its ocular screening. Review

Journal of Medicine and Life

Hydroxychloroquine sulfate (HCQ, Plaquenil) is an analogue of chloroquine (CQ), an antimalarial agent, used for the treatment of systemic lupus erythematosus, rheumatoid arthritis and other autoimmune disorders. Its use has been associated with severe retinal toxicity, requiring a discontinuation of therapy. Because it presents potential secondary effects including irreversible maculopathy, knowledge of incidence, risk factors, drug toxicity and protocol screening of the patients it represents important data for the ophthalmologists. Thus, it is imperative that rheumatologists, medical internists and ophthalmologists are aware of the toxicity from hydroxychloroquine they should also be careful to minimize its occurrence and effects

READ MORE A THE JOURNAL OF MEDICINE AND LIFE


Advertisements